Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock ...

Rithm Property Trust's RPT-C preferred stock offers a 9.875% fixed dividend until 2030, then a floating rate based on SOFR.

Park Ha operates in a large, fast-growing market but faces intense competition and rising costs, impacting profitability. See ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

Case Lake project shows promise with high-grade cesium, lithium, and tantalum mineralization. See why I rate the stock a buy.

For Q4 2024, the John Hancock U.S. Global Leaders Growth fund posted a small gain that trailed the return of its benchmark ...

FirstEnergy's lackluster dividend growth and limited capital appreciation make it less attractive compared to peers. Find out ...

Semrush Holdings basically offers an AI-enhanced SaaS platform for digital marketing. Click here to read why SEMR stock is a ...

Tesla's deferred FSD revenue and limited Robotaxi rollout show promise, but currently lack meaningful financial impact. Read ...

Puma SE is poised for a turnaround with strong growth plans in the US market and strategic athlete endorsements. Read why ...

For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the ...

DiDi Global (DIDIY) dominates China's shared mobility market with strong profitability growth and competitive advantages. See ...